CXCL11 and pulmonary fibrosis: Interferon‐inducible T cell (I‐TAC, or CXCL11), a chemoattractant, has been found to attenuate bleomycin‐induced mouse model lung fibrosis with systemic treatment by inhibiting vascular remodeling.44